Cellular and humoral immunity in patients with insulin-dependent diabetes
暂无分享，去创建一个
J. Newsom-Davis | N. Pantic | N. Willcox | S. Hawke | G. Harcourt | A. Bansal | R. Pumphrey | D. Beeson | P. Wilson | AndrewJ.M. Boulton | RayazA. Malik
[1] W. Ollier,et al. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. , 1993, Immunology.
[2] A. Vincent,et al. Approaches for Studying the Pathogenic T Cells in Autoimmune Patients a , 1993, Annals of the New York Academy of Sciences.
[3] L. Harrison,et al. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin- dependent diabetes , 1993, The Journal of experimental medicine.
[4] A. Vincent,et al. Stimulation of human T cells by sparse antigens captured on immunomagnetic particles. , 1992, Journal of immunological methods.
[5] E. Hay,et al. Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus , 1992, Clinical and experimental immunology.
[6] J. Gordon. CD23 and B cell activation , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[7] P Wordsworth,et al. Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Bassey,et al. T‐Cell Recognition of Bacterial Heat‐Shock Proteins in Inflammatory Arthritis , 1991, Immunological reviews.
[9] A. Vincent,et al. Human muscle acetylcholine receptor: cloning and expression in Escherichia coli of cDNA for the α-subunit , 1989 .